SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MANFRINATO, Maria Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.004
AS - Asia 2.595
EU - Europa 1.776
SA - Sud America 425
AF - Africa 52
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
Totale 9.865
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.913
SG - Singapore 974
CN - Cina 865
BR - Brasile 355
UA - Ucraina 313
IT - Italia 308
DE - Germania 304
HK - Hong Kong 255
GB - Regno Unito 207
TR - Turchia 156
VN - Vietnam 146
FI - Finlandia 132
PL - Polonia 115
RU - Federazione Russa 95
SE - Svezia 79
CA - Canada 46
ID - Indonesia 39
MX - Messico 37
EE - Estonia 36
FR - Francia 33
AR - Argentina 30
NL - Olanda 28
IN - India 27
BE - Belgio 26
JP - Giappone 22
CZ - Repubblica Ceca 21
ZA - Sudafrica 21
BD - Bangladesh 17
IQ - Iraq 17
ES - Italia 15
LT - Lituania 13
CO - Colombia 11
EC - Ecuador 11
IR - Iran 10
IE - Irlanda 8
MA - Marocco 8
MY - Malesia 8
SA - Arabia Saudita 8
AT - Austria 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
KR - Corea 6
PY - Paraguay 6
RO - Romania 6
SD - Sudan 6
UY - Uruguay 6
BG - Bulgaria 5
PT - Portogallo 5
TW - Taiwan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
EU - Europa 4
PK - Pakistan 4
AU - Australia 3
CL - Cile 3
JM - Giamaica 3
KE - Kenya 3
KW - Kuwait 3
MD - Moldavia 3
NP - Nepal 3
OM - Oman 3
TN - Tunisia 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
IL - Israele 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PA - Panama 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
GN - Guinea 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KZ - Kazakistan 1
LB - Libano 1
MK - Macedonia 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
SV - El Salvador 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
Totale 9.865
Salva come PNG Salva come JPEG
Città #
Singapore 543
Woodbridge 521
Ashburn 449
Fairfield 340
Jacksonville 331
Chandler 324
Beijing 315
Houston 309
Santa Clara 284
Ann Arbor 281
Hong Kong 251
Wilmington 139
Dallas 129
Ferrara 129
Cambridge 113
Seattle 111
Nanjing 110
Warsaw 101
Izmir 100
Munich 87
Princeton 81
Los Angeles 77
Boardman 66
Dearborn 57
Ho Chi Minh City 52
Milan 45
New York 45
Nanchang 37
Shanghai 37
Shenyang 35
San Diego 33
Turku 33
Helsinki 32
São Paulo 31
Tianjin 30
Changsha 29
London 28
Brussels 26
Hanoi 26
Mexico City 25
Bologna 23
Buffalo 22
Jakarta 20
Tokyo 20
Bremen 19
Brno 18
Brooklyn 17
Hefei 17
Jiaxing 17
Poplar 17
Chicago 16
Hebei 16
Montreal 15
Moscow 15
Ningbo 15
Orange 15
Addison 14
Chennai 14
Denver 14
Boston 13
Frankfurt am Main 13
Jinan 13
Norwalk 13
Phoenix 13
San Francisco 12
San Mateo 12
Redwood City 11
Stockholm 11
Toronto 11
Augusta 10
Mountain View 10
Orem 10
Atlanta 9
Auburn Hills 9
Curitiba 9
Dong Ket 9
Kraków 9
Philadelphia 9
Washington 9
Dublin 8
Johannesburg 8
Manchester 8
The Dalles 8
Des Moines 7
Falkenstein 7
Falls Church 7
Guangzhou 7
Leawood 7
Verona 7
Ankara 6
Casalecchio Di Reno 6
Charlotte 6
Montréal 6
Quito 6
Rio de Janeiro 6
Rome 6
Zhengzhou 6
Amsterdam 5
Baghdad 5
Buenos Aires 5
Totale 6.468
Salva come PNG Salva come JPEG
Nome #
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 229
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 209
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 200
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 192
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 177
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 175
Mutual communication of envelope glycoproteins of paramixoviruses 173
Anomeric specificity and protein-substrate interactions support the 3D model for the hemagglutinin-neuraminidase from Sendai virus 171
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 167
Antiproliferative effects of novel synthetic nucleobase analogues on U937 Histiocytic lymphoma cell line 160
Schematic overview of oligosaccharides, with survey on their major physiological effects and a focus on milk ones 160
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 159
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 156
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 153
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 153
Fast skeletal troponin i, but not the slow isoform, is increased in patients under statin therapy: A pilot study 153
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 151
Substrate binding to 6-phosphogluconate dehydrogenase 150
Peptides derived from the heptad repeat region near the C-terminal of Sendai virus F protein bind the hemagglutinin-neuraminidase ectodomain 149
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 148
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 148
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 148
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 148
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 147
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 142
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 139
Conformational transitions during thermal inactivation of the neuraminidase from sendai virus 136
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 135
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 133
Thermal stability of the hemagglutinin-neuraminidase from Sendai virus evidences two folding domains 130
Biochemical study in adult population with stroke in Ferrara, Fabry disease 129
null 128
Limited preotolysis of cHN, the soluble hemagglutinin neuraminidase from sendai virus 125
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 125
Studies of Interaction between Sendai Virus Envelope Glycoproteins (HN ad F) by Syntetic peptides derived from the HR2 Region of the F Protein 122
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 122
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 122
SERUM GELATINASES LEVELS IN MULTIPLE SCLEROSIS PATIENTS DURING 21 MONTHS OF NATALIZUMAB TREATMENT 120
Domain structure of the hemagglutinin-neuraminidase from sendai virus 118
Selective inhibition of Trypanosoma brucei 6-phosphogluconate dehydrogenase by high energy intermediate and transition state analogues 117
Catalytic mechanism of 6-phosphogluconate dehydrogenase investigated by site-directed mutagenesis 115
Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study 112
Inflammation and axonal damage biomarkers in Multiple Sclerosis: new perspective on their role 112
A Calcium- and GTP-Dependent Transglutaminase in Leishmania infantum 110
null 110
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis 108
null 104
Fluids administration modulate the matrix metalloproteinase-9 (MMP-9), myeloperoxidase (MPO) activities and inflammatory neutrophils response 104
Matrix metalloproteinase-2 (MMP-2) immune functions via surface proteolytic shedding of HLA-G1 molecules 104
Heparin binds Matrix Metalloproteinase-9 (MMP-9): effect on the proteolytic activity 104
Gelatinases: enzymatic activity as potential biomarker in multiple sclerosis 104
Gelatinase: enzymatic activity as potential biomarker in multiple sclerosis 104
Extracellular pH modulates the release of Matrix Metalloproteinase-9 (MMP-9) by stimulated neutrophils and its activity. 104
Purification of transglutaminase enzyme from L. infantum promastigotes 103
Active myeloperoxidase: a promising biomarker to differentiate “acute” and “low-grade” peri-prosthetic joint infections from aseptic failures 102
Possibile association between cerebrospinal fluid and serum levels of active matrix metalloproteinase-2 and MRI inactivity in multiple sclerosis patients 98
Enzymatic activation of NCX4016, a nitrate ester derivative of Aspirin 98
null 97
Unfording and limited proteolysis of the hemagglutinin-neuraminidase from sendai virus 94
Thermodynamic characterization of 6-phosphogluconate dehydrogenase ternary complex 94
Partial unfolding of the hemagglutinin-neuraminidase from sendai virus 90
Matrix Metalloprotease-9 activity detected in body fluids is the result of two different enzyme forms 90
Influence of 6-aminonicotinamide (6AN) on Leishmania promastigotes evaluated by metabolomics: beyond the pentose phosphate pathway 89
Synthetic peptides corresponding to the heptad repeat region of sendai virus fusion protein bind to the hemagglutinin-neuraminidase 89
MMP-9 isoforms in serum of Multiple Sclerosis patients 88
null 88
Effects of anticoagulants on the activity of gelatinases 88
Xenobiotics biodegradation: recombinant DCM dehalogenase from alcaligenes xylosoxydans 87
Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 87
Gelatinase A (MMP-2) and B (MMP-9): their active forms as biomarkers in multiple sclerosis 85
Fluids administration can modulate inflammatory neutrophils response and MMP-9 activity: an in vitro study 84
Differential pathogenicity and lethality of bubonic plague (1720–1945) by sex, age and place 83
Modulation of metalloproteinase-9 (MMP-9) by its specific tissue inhibitor (TIMP1) 79
The influence of different replacement solutions on neutrophils response 79
inhibition of sendai virus fusion protein by interaction synthetic peptides derived F protein and hemagglutinin-neuraminidase 78
Effects of anticoagulants on the activity of gelatinases 73
pH dependent structural changes of the hemagglutinin-neuraminidase from sendai virus 65
Vaginal Lactoferrin Administration Decreases Oxidative Stress in the Amniotic Fluid of Pregnant Women: An Open-Label Randomized Pilot Study 65
Effects of two different strategies of fluid administration on inflammatory mediators, plasma electrolytes and acid/base disorders in patients undergoing major abdominal surgery: a randomized double blind study. 64
Sex-Related Differences of Matrix Metalloproteinases (MMPs): New Perspectives for These Biomarkers in Cardiovascular and Neurological Diseases 60
Chemical and biological versatility of pyrazolo[3,4-d]pyrimidines: one scaffold, multiple modes of action 55
Lactoferrin administration prior to genetic amniocentesis dampens the intraamniotic inflammatory response 55
null 53
null 49
Influence of different strategies of volume replacement on the activity of metalloproteinases 9 42
Commentary on the Issue of Leishmania Infection: Focus on Some Pathogenetic, Clinical, and Epidemiological Aspects 27
Totale 9.992
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.678
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.678
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021573 0 0 0 0 0 100 54 93 24 121 139 42
2021/2022639 21 70 26 21 27 25 19 25 19 71 45 270
2022/2023791 77 66 20 95 134 106 47 69 84 11 52 30
2023/2024407 42 48 16 15 61 40 10 24 17 12 8 114
2024/20251.818 49 42 153 73 216 152 68 98 263 232 276 196
2025/20262.487 502 227 410 610 685 53 0 0 0 0 0 0
Totale 9.992